DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...

Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...

The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...

The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week. Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs ...

Testing blood sugar frequently and administering insulin as needed throughout the day isn't easy, especially if the individual with diabetes is a young child who can't do it on their own yet. Now, ...

An MD+DI headline from September 2020 poses this question: Could MiniMed 770G's approval boost Medtronic's position in diabetes? It seems the answer, so far, is yes. Medtronic CEO Geoff Martha told ...

The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic. The FDA has approved Medtronic’s MiniMed 780G system with Guardian 4 ...

Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps "Mealtimes prove to be one of the biggest ...

Knoxville-area mom Crystal had always been diligent with the health of her two sons. Now teens, they’re both active with hearty, and mostly healthy, appetites. So when her younger son, Landyn, was ...

With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...